Association between the Triglyceride–Glucose Index and Non-Alcoholic Fatty Liver Disease in patients with Atrial Fibrillation

Table 2 Association of the triglycerides–glucose index with risk of non-alcoholic fatty liver diseases

TyG index	Case/N	Crude model OR (95%CI)	P	Model I OR (95%CI)	P	Model II OR (95%CI)	P
Per 1 unit increase	176/632	4.51 (3.21, 6.34)	< 0.001	3.59 (2.40, 5.36)	< 0.001	3.27 (2.13, 5.02)	< 0.001
Tertiles
T1 (≤ 8.29)	37/211	Ref.	1.0	Ref.	1.0	Ref.	1.0
T2 (8.29–8.82)	46/210	2.63 (1.55, 4.45)	< 0.001	2.54 (1.47, 4.39)	< 0.001	2.22 (1.24, 3.98)	0.007
T3 (≥ 8.82)	93/211	6.89 (4.16, 11.40)	< 0.001	4.97 (2.73, 8.40)	< 0.001	4.07 (2.24, 7.39)	< 0.001
P for trend		< 0.001		< 0.001		< 0.001

Crude model was unadjusted for any factors; Model I was adjusted for age, gender, AF type, dyslipidemia, and diabetes. Model II was adjusted for Model I, BMI, eGFR, AST, ALT, HDL-C, UA, duration of AF, hypertension, and smoking
95% CI 95% confidence interval, OR odds ratio, TyG triglyceride–glucose, BMI body mass index, eGFR estimated glomerular filtration rate, AST aspartate aminotransferase, ALT alanine aminotransferase, HDL-C high-density lipoprotein cholesterol, UA uric acid

ISSN: 2047-783X